Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Jun 18, 2026
- Accession no.
- 0001106578-26-000081
- Filed
- Jun 18, 2026
- Trade date
- Jun 17, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.25M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $146.03 | +$1,387,285 | 50,013 | Direct | |
| Jun 17, 2026 | Common Stock | SSaleDisposed | −560 | $548.57F2 | −$307,199.2 | 49,453 | Direct | |
| Jun 17, 2026 | Common Stock | SSaleDisposed | −612 | $549.57F3 | −$336,336.84 | 48,841 | Direct | |
| Jun 17, 2026 | Common Stock | SSaleDisposed | −2,077 | $550.87F4 | −$1,144,156.99 | 46,764 | Direct | |
| Jun 17, 2026 | Common Stock | SSaleDisposed | −1,840 | $551.73F5 | −$1,015,183.2 | 44,924 | Direct | |
| Jun 17, 2026 | Common Stock | SSaleDisposed | −727 | $552.75F6 | −$401,849.25 | 44,197 | Direct | |
| Jun 17, 2026 | Common Stock | SSaleDisposed | −1,201 | $553.78F7 | −$665,089.78 | 42,996 | Direct | |
| Jun 17, 2026 | Common Stock | SSaleDisposed | −1,909 | $554.77F8 | −$1,059,055.93 | 41,087 | Direct | |
| Jun 17, 2026 | Common Stock | SSaleDisposed | −574 | $555.63F9 | −$318,931.62 | 40,513 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 12,410 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $548.13 to $549.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $549.14 to $550.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $550.19 to $551.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $551.23 to $552.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $552.285 to $553.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $553.30 to $554.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $554.30 to $555.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $555.55 to $555.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.